This is the authors' abstract. We don't add key points for this paper.
Hepatitis C infection following orthotopic liver transplantation may lead to progressive chronic graft dysfunction. In this study, seven liver transplant recipients with chronic allograft dysfunction due to hepatitis C infection (one acquired and six recurrent infections) were treated with oral ribavirin for 6 months. Symptoms of lethargy, nausea and anorexia improved in all patients within 2 weeks of starting the drug, with a fall in serum AST of at least 40 % by this time. Ribavirin-induced haemolysis was clinically
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Gane et al. (1995) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: